Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent

ClinicalTrials.gov ID: NCT00506493

Public ClinicalTrials.gov record NCT00506493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Persistent Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This investigation is a prospective, nonrandomized multicenter clinical trial evaluating the outcome of patients with atrial fibrillation (AF) requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass graft (CABG) procedures. The study objectives are to demonstrate that the Medtronic Cardioblate Surgical Ablation System can safely and effectively treat persistent AF patients.

Study identification

NCT ID
NCT00506493
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medtronic Cardiac Surgery
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

Device · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2007 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Oct 2011 (Actual)
Last update posted
Nov 29, 2023

2007 – 2011

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Southwest Heart and Lung Phoenix Arizona 85260 —
East Bay Cardiovascular & Thoracic Associates Concord California 94520 —
University of Southern California Los Angeles California 90033 —
Eisenhower Medical Center Palm Springs California 92270 —
Cardiac Surgical Associates of Florida St. Petersburg Florida 33701 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Mayo/St. Mary's Hospital Rochester Minnesota 55902 —
Washington University School of Medicine St Louis Missouri 63310 —
Englewood Hospital and Medical Center Englewood New Jersey 07631 —
New Mexico Heart Institute Albuquerque New Mexico 87102 —
Lenox Hill Hospital New York New York 10075 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Hospital of University of Pennsylvania Philadelphia Pennsylvania 19104 —
Inova Fairfax Falls Church Virginia 22042 —
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53515 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00506493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00506493 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →